Table 2b.

Incremental Area Under the curve (AUC) for counter-regulatory hormone release (from 40 to 220 min) ± SD.

	GCK-MODY	Type 2 diabetes	p-value GCK-MODY vs Type 2 diabetes	Healthy controls	p-value GCK-MODY vs Healthy controls	p-value Type 2 diabetes vs Healthy controls
Glucagon/pg ml−1	10,070 ± 8929	984 ± 5412	0.01	416 ± 4148	0.01	0.8
Epinephrine/nmol L−1	354 ± 176	136 ± 51	0.005	69 ± 65	0.001	0.09
Norepinephrine/nmol L−1	117 ± 166	62 ± 35	0.8	26 ± 40	0.07	0.09
Cortisol/nmol L−1	36,269 ± 34,048	25,858 ± 35,477	0.6	1973 ± 17,044	0.02	0.09
Growth Hormone/mu L−1	2550 ± 2159	1291 ± 799	0.2	445 ± 1345	0.04	0.2
Pancreatic polypeptide/pmol L−1	9632 ± 5992	12,000 ± 8880	0.7	1261 ± 1294	0.001	0.003